Data is not available at this time.
Nisshin Seifun Group Inc. operates as a diversified food and biotechnology company with a strong presence in Japan and select international markets. Its core business segments include flour milling, processed foods, health foods, and pet foods, supported by ancillary operations in biotechnology, engineering, and industrial mesh products. The company leverages well-established brands such as NISSHIN, MA?MA, and DE CECCO to drive consumer loyalty in packaged foods, while its JP Style pet food line capitalizes on Japan's growing pet care market. Nisshin Seifun’s vertically integrated model allows it to control quality and costs across its supply chain, from raw material processing to finished goods. Its engineering division further enhances operational efficiency by designing specialized food and chemical processing facilities. The company’s diversified revenue streams and strong domestic market share position it as a resilient player in the consumer defensive sector, though international expansion remains limited compared to global peers.
In FY 2024, Nisshin Seifun reported revenue of JPY 858.2 billion, with net income of JPY 31.7 billion, reflecting a net margin of approximately 3.7%. Operating cash flow stood at JPY 73.2 billion, supported by stable demand for staple food products. Capital expenditures of JPY 29.2 billion indicate ongoing investments in production capacity and efficiency improvements, though free cash flow generation remains moderate relative to revenue scale.
The company’s diluted EPS of JPY 106.74 underscores its ability to generate earnings despite competitive pressures in the packaged food industry. Its capital efficiency is tempered by the capital-intensive nature of flour milling and food processing, though its biotechnology and engineering segments may offer higher-margin growth opportunities over time.
Nisshin Seifun maintains a solid balance sheet with JPY 107.7 billion in cash and equivalents against total debt of JPY 88.3 billion, indicating manageable leverage. The liquidity position provides flexibility for strategic investments or dividend payouts, though the debt-to-equity ratio suggests moderate financial risk given the industry’s low volatility.
Revenue growth has been steady but unspectacular, aligned with Japan’s mature food market. The company’s dividend per share of JPY 55 reflects a conservative payout policy, prioritizing reinvestment in core operations and niche segments like health foods and pet care. Long-term growth may hinge on biotechnology innovations or overseas expansion, though these remain secondary to domestic stability.
With a market capitalization of JPY 502.4 billion and a beta of -0.024, Nisshin Seifun is perceived as a low-volatility defensive stock. Its valuation multiples likely reflect modest growth expectations, with investors valuing its consistent cash flows and dividend yield over aggressive expansion.
Nisshin Seifun’s strengths lie in its diversified product portfolio, strong brand equity, and operational integration. However, its reliance on the Japanese market and limited global footprint may constrain long-term growth. The company’s focus on health foods and biotechnology could unlock higher margins, but execution risks remain. Near-term performance will likely mirror domestic consumption trends, with incremental gains from efficiency initiatives.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |